134 related articles for article (PubMed ID: 27734750)
1. Association of anandamide with altered binocular depth inversion illusion in schizophrenia.
Reuter AR; Bumb JM; Mueller JK; Rohleder C; Pahlisch F; Hanke F; Arens E; Leweke FM; Koethe D; Schwarz E
World J Biol Psychiatry; 2017 Sep; 18(6):483-488. PubMed ID: 27734750
[TBL] [Abstract][Full Text] [Related]
2. Neural correlates of binocular depth inversion illusion in antipsychotic-naïve first-episode schizophrenia patients.
Rohleder C; Koethe D; Fritze S; Topor CE; Leweke FM; Hirjak D
Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):897-910. PubMed ID: 29556734
[TBL] [Abstract][Full Text] [Related]
3. Anandamide dysfunction in prodromal and established psychosis.
Leweke FM
Curr Pharm Des; 2012; 18(32):5188-93. PubMed ID: 22716147
[TBL] [Abstract][Full Text] [Related]
4. Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use.
Leweke FM; Giuffrida A; Koethe D; Schreiber D; Nolden BM; Kranaster L; Neatby MA; Schneider M; Gerth CW; Hellmich M; Klosterkötter J; Piomelli D
Schizophr Res; 2007 Aug; 94(1-3):29-36. PubMed ID: 17566707
[TBL] [Abstract][Full Text] [Related]
5. Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naïve and treated schizophrenia.
Koethe D; Kranaster L; Hoyer C; Gross S; Neatby MA; Schultze-Lutter F; Ruhrmann S; Klosterkötter J; Hellmich M; Leweke FM
Eur Arch Psychiatry Clin Neurosci; 2009 Jun; 259(4):195-202. PubMed ID: 19165523
[TBL] [Abstract][Full Text] [Related]
6. Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis.
Koethe D; Giuffrida A; Schreiber D; Hellmich M; Schultze-Lutter F; Ruhrmann S; Klosterkötter J; Piomelli D; Leweke FM
Br J Psychiatry; 2009 Apr; 194(4):371-2. PubMed ID: 19336792
[TBL] [Abstract][Full Text] [Related]
7. Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study.
Potvin S; Lungu OV; Stip E
J Clin Psychopharmacol; 2015 Feb; 35(1):82-3. PubMed ID: 25370126
[No Abstract] [Full Text] [Related]
8. Cannabinoid/anandamide system and schizophrenia: is there evidence for association?
Schneider U; Leweke FM; Mueller-Vahl KR; Emrich HM
Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():110-3. PubMed ID: 9754842
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms.
Morgan CJ; Page E; Schaefer C; Chatten K; Manocha A; Gulati S; Curran HV; Brandner B; Leweke FM
Br J Psychiatry; 2013 May; 202(5):381-2. PubMed ID: 23580381
[TBL] [Abstract][Full Text] [Related]
10. Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness.
Koethe D; Gerth CW; Neatby MA; Haensel A; Thies M; Schneider U; Emrich HM; Klosterkötter J; Schultze-Lutter F; Leweke FM
Schizophr Res; 2006 Dec; 88(1-3):142-50. PubMed ID: 17005373
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms.
Giuffrida A; Leweke FM; Gerth CW; Schreiber D; Koethe D; Faulhaber J; Klosterkötter J; Piomelli D
Neuropsychopharmacology; 2004 Nov; 29(11):2108-14. PubMed ID: 15354183
[TBL] [Abstract][Full Text] [Related]
12. Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans.
Thieme U; Schelling G; Hauer D; Greif R; Dame T; Laubender RP; Bernhard W; Thieme D; Campolongo P; Theiler L
Drug Test Anal; 2014; 6(1-2):17-23. PubMed ID: 24424856
[TBL] [Abstract][Full Text] [Related]
13. Familial abnormalities of endocannabinoid signaling in schizophrenia.
Koethe D; Pahlisch F; Hellmich M; Rohleder C; Mueller JK; Meyer-Lindenberg A; Torrey EF; Piomelli D; Leweke FM
World J Biol Psychiatry; 2019 Feb; 20(2):117-125. PubMed ID: 29521179
[TBL] [Abstract][Full Text] [Related]
14. Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid.
Koethe D; Schreiber D; Giuffrida A; Mauss C; Faulhaber J; Heydenreich B; Hellmich M; Graf R; Klosterkötter J; Piomelli D; Leweke FM
J Neural Transm (Vienna); 2009 Mar; 116(3):301-5. PubMed ID: 19137236
[TBL] [Abstract][Full Text] [Related]
15. Leptin levels are negatively correlated with 2-arachidonoylglycerol in the cerebrospinal fluid of patients with osteoarthritis.
Nicholson J; Azim S; Rebecchi MJ; Galbavy W; Feng T; Reinsel R; Rizwan S; Fowler CJ; Benveniste H; Kaczocha M
PLoS One; 2015; 10(4):e0123132. PubMed ID: 25835291
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.
Leweke FM; Piomelli D; Pahlisch F; Muhl D; Gerth CW; Hoyer C; Klosterkötter J; Hellmich M; Koethe D
Transl Psychiatry; 2012 Mar; 2(3):e94. PubMed ID: 22832859
[TBL] [Abstract][Full Text] [Related]
17. Elevated endogenous cannabinoids in schizophrenia.
Leweke FM; Giuffrida A; Wurster U; Emrich HM; Piomelli D
Neuroreport; 1999 Jun; 10(8):1665-9. PubMed ID: 10501554
[TBL] [Abstract][Full Text] [Related]
18. Decreased circulating anandamide levels in preeclampsia.
Molvarec A; Fügedi G; Szabó E; Stenczer B; Walentin S; Rigó J
Hypertens Res; 2015 Jun; 38(6):413-8. PubMed ID: 25716652
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation.
Patsenker E; Sachse P; Chicca A; Gachet MS; Schneider V; Mattsson J; Lanz C; Worni M; de Gottardi A; Semmo M; Hampe J; Schafmayer C; Brenneisen R; Gertsch J; Stickel F; Semmo N
Int J Mol Sci; 2015 Mar; 16(4):7057-76. PubMed ID: 25826533
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy.
Romigi A; Bari M; Placidi F; Marciani MG; Malaponti M; Torelli F; Izzi F; Prosperetti C; Zannino S; Corte F; Chiaramonte C; Maccarrone M
Epilepsia; 2010 May; 51(5):768-72. PubMed ID: 19817812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
